Tecfidera and Strattera drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tecfidera (dimethyl fumarate) and Strattera (atomoxetine hydrochloride). Common drug interactions include flushing among females and flushing among males.

The phase IV clinical study analyzes what interactions people have when they take Tecfidera and Strattera. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Tecfidera?

Tecfidera has active ingredients of dimethyl fumarate. It is often used in multiple sclerosis. eHealthMe is studying from 129,627 Tecfidera users. Check the latest studies of Tecfidera.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,324 Strattera users. Check the latest studies of Strattera.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

34 people who take Tecfidera and Strattera together, and have interactions are studied.

Tecfidera and Strattera drug interactions.

What are the common drug interactions of Tecfidera and Strattera, by gender? *:

female:

  1. Flushing (the warm, red condition of human skin)
  2. Drug ineffective
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Gait disturbance
  5. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  6. Nausea (feeling of having an urge to vomit)
  7. Feeling hot
  8. Pruritus (severe itching of the skin)
  9. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  10. Hemiparesis (weakness on one side of the body)

male:

  1. Flushing (the warm, red condition of human skin)
  2. Fatigue (feeling of tiredness)
  3. Memory impairment
  4. Urinary retention (the inability to completely or partially empty the bladder)
  5. Visual impairment
  6. Chest pain
  7. Lymphocyte count decreased
  8. Cardiac disorder
  9. Bladder disorder
  10. Constipation

What are the common drug interactions of Tecfidera and Strattera, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Drug ineffective
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  5. Gait disturbance
  6. Hemiparesis (weakness on one side of the body)
  7. Flushing (the warm, red condition of human skin)
  8. Miliaria (a skin disease marked by small and itchy rashes)
  9. Nausea (feeling of having an urge to vomit)

30-39:

  1. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  2. Abdominal pain upper
  3. Blood pressure decreased
  4. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
  5. Diarrhoea
  6. Haematochezia (passage of stools containing blood)
  7. Maternal exposure during pregnancy (use of substance during pregnancy)
  8. Vasculitis (inflammation of a blood vessel or blood vessels)

40-49:

  1. Flushing (the warm, red condition of human skin)
  2. Alopecia (absence of hair from areas of the body)
  3. Erythema (redness of the skin)
  4. Feeling hot
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  6. Pruritus (severe itching of the skin)
  7. Stomatitis (inflammation of mucous membrane of mouth)
  8. Nausea (feeling of having an urge to vomit)
  9. Abasia (inability to walk)
  10. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)

50-59:

  1. Flushing (the warm, red condition of human skin)
  2. Fall
  3. Pruritus (severe itching of the skin)
  4. Rash macular (small, flat red spots)
  5. Vomiting
  6. Abdominal pain upper
  7. Breast cancer
  8. Diarrhoea
  9. White blood cell count decreased
  10. Bladder disorder

60+:

n/a

What are the existing conditions these people have? *

  1. Headache (pain in head): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Tecfidera and Strattera?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tecfidera and Strattera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tecfidera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Strattera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tecfidera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Strattera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dimethyl fumarate and atomoxetine hydrochloride (the active ingredients of Tecfidera and Strattera, respectively), and Tecfidera and Strattera (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: